When thrombin is added to platelet rich plasma at very low concentrations (0.02 U/ml), platelets undergo an activation process. Under these conditions platelets discharge beta-thromboglobulin, platelet factor 4 and the "platelet derived growth factor". In this paper we present evidence that when human platelets are weakly stimulated with thrombin, the number of openings of the surface connected canalicular system (SCCS) increases. Analogous SCCS increase was observed in hypercholesterolemic rabbits as well in humans (familial hyperchoelsterolemia). 8-chlorocarbochromen (AD6), an antiaggregating drug, inhibits the SCSS in vitro increase while acetylsalicylic acid was uneffective.
Bianciardi, G., Toti, P., Weber, G. (1987). The increase of openings of the surface-connected canalicular system in weekly stimulated platelets is prevented by a carbochromen derivative. A computerized morphometric analylis of freeze-etched human platelets plasma-membrane. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 19(9), 579-589 [10.1016/0031-6989(87)90112-3].
The increase of openings of the surface-connected canalicular system in weekly stimulated platelets is prevented by a carbochromen derivative. A computerized morphometric analylis of freeze-etched human platelets plasma-membrane
Bianciardi, Giorgio;Toti, Paolo;
1987-01-01
Abstract
When thrombin is added to platelet rich plasma at very low concentrations (0.02 U/ml), platelets undergo an activation process. Under these conditions platelets discharge beta-thromboglobulin, platelet factor 4 and the "platelet derived growth factor". In this paper we present evidence that when human platelets are weakly stimulated with thrombin, the number of openings of the surface connected canalicular system (SCCS) increases. Analogous SCCS increase was observed in hypercholesterolemic rabbits as well in humans (familial hyperchoelsterolemia). 8-chlorocarbochromen (AD6), an antiaggregating drug, inhibits the SCSS in vitro increase while acetylsalicylic acid was uneffective.File | Dimensione | Formato | |
---|---|---|---|
Pharmacol 1987.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
3.65 MB
Formato
Adobe PDF
|
3.65 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/19831
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo